We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Patent Pressures Mounting for Pandemic Flu Drug Manufacturers
Patent Pressures Mounting for Pandemic Flu Drug Manufacturers
November 16, 2005
Antiviral manufacturers such as Roche and GlaxoSmithKline (GSK) are under increasing pressure to allow generic production of their vaccines, which could be effective against an avian flu outbreak, but industry opponents say opening the door for generics isn’t the solution.